The stock of Larimar Therapeutics Inc (LRMR) has gone up by 27.27% for the week, with a -6.30% drop in the past month and a -30.61% drop in the past quarter. The volatility ratio for the week is 9.59%, and the volatility levels for the past 30 days are 10.14% for LRMR.. The simple moving average for the past 20 days is 17.41% for LRMR’s stock, with a -57.95% simple moving average for the past 200 days.
Is It Worth Investing in Larimar Therapeutics Inc (NASDAQ: LRMR) Right Now?
Moreover, the 36-month beta value for LRMR is 0.96. Analysts have varying opinions on the stock, with 10 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for LRMR is 36.68M and currently, short sellers hold a 13.13% of that float. On April 23, 2025, LRMR’s average trading volume was 766.63K shares.
LRMR) stock’s latest price update
Larimar Therapeutics Inc (NASDAQ: LRMR)’s stock price has gone rise by 18.41 in comparison to its previous close of 2.01, however, the company has experienced a 27.27% increase in its stock price over the last five trading days. globenewswire.com reported 2025-03-24 that BALA CYNWYD, Pa., March 24, 2025 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today reported its fourth quarter and full year 2024 operating and financial results.
Analysts’ Opinion of LRMR
Many brokerage firms have already submitted their reports for LRMR stocks, with Truist repeating the rating for LRMR by listing it as a “Buy.” The predicted price for LRMR in the upcoming period, according to Truist is $18 based on the research report published on January 29, 2025 of the current year 2025.
Oppenheimer, on the other hand, stated in their research note that they expect to see LRMR reach a price target of $26. The rating they have provided for LRMR stocks is “Outperform” according to the report published on October 16th, 2024.
Wedbush gave a rating of “Outperform” to LRMR, setting the target price at $22 in the report published on October 03rd of the previous year.
LRMR Trading at -6.86% from the 50-Day Moving Average
After a stumble in the market that brought LRMR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -78.75% of loss for the given period.
Volatility was left at 10.14%, however, over the last 30 days, the volatility rate increased by 9.59%, as shares surge +4.39% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -31.21% lower at present.
During the last 5 trading sessions, LRMR rose by +27.27%, which changed the moving average for the period of 200-days by -68.81% in comparison to the 20-day moving average, which settled at $2.03. In addition, Larimar Therapeutics Inc saw -38.50% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for LRMR
The total capital return value is set at -0.52. Equity return is now at value -63.58, with -54.30 for asset returns.
Based on Larimar Therapeutics Inc (LRMR), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -13.83.
Currently, EBITDA for the company is -90.89 million with net debt to EBITDA at 0.31. The liquidity ratio also appears to be rather interesting for investors as it stands at 8.02.
Conclusion
To wrap up, the performance of Larimar Therapeutics Inc (LRMR) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
